- Home
- / Myovant Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Myovant Sciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$231 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|
| Revenue | 59.3M | 231.0M | ||||
| General and administrative expense | 12.4M | 24.2M | 42.2M | 82.3M | 181.4M | 259.4M |
| Operating expense total | 55.9M | 141.1M | 264.8M | 274.9M | 323.0M | |
| EBIT | (83.5M) | (143.0M) | (273.1M) | (260.8M) | (187.3M) | |
| EBIT margin, % | -439.6% | |||||
| Interest expense | 2.0M | 8.8M | 10.4M | 14.0M | ||
| Pre tax profit | (83.5M) | (143.0M) | (273.1M) | (288.2M) | (254.8M) | (200.9M) |
| Income tax expense | (74.0K) | 213.0K | 476.0K | 761.0K | 336.0K | 5.0M |
| Net Income | (83.4M) | (143.3M) | (273.6M) | (289.0M) | (255.1M) | (206.0M) |